Go Pro

Molina Healthcare (MOH) Competitors

Molina Healthcare logo
$243.34 +10.03 (+4.30%)
Closing price 03:59 PM Eastern
Extended Trading
$241.12 -2.22 (-0.91%)
As of 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MOH vs. CI, CNC, ELV, HCA, and HUM

Should you buy Molina Healthcare stock or one of its competitors? MarketBeat compares Molina Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Molina Healthcare include Cigna Group (CI), Centene (CNC), Elevance Health (ELV), HCA Healthcare (HCA), and Humana (HUM). These companies are all part of the "medical" sector.

How does Molina Healthcare compare to Cigna Group?

Cigna Group (NYSE:CI) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

Cigna Group has a net margin of 2.26% compared to Molina Healthcare's net margin of 0.42%. Cigna Group's return on equity of 19.75% beat Molina Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Cigna Group2.26% 19.75% 5.30%
Molina Healthcare 0.42%8.76%2.32%

Cigna Group has a beta of 0.29, suggesting that its share price is 71% less volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

Cigna Group has higher revenue and earnings than Molina Healthcare. Cigna Group is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cigna Group$274.90B0.29$5.96B$23.5912.91
Molina Healthcare$45.08B0.28$472M$3.3871.99

Cigna Group presently has a consensus price target of $338.80, indicating a potential upside of 11.23%. Molina Healthcare has a consensus price target of $194.50, indicating a potential downside of 20.07%. Given Cigna Group's stronger consensus rating and higher possible upside, research analysts plainly believe Cigna Group is more favorable than Molina Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cigna Group
0 Sell rating(s)
6 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.77
Molina Healthcare
1 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.12

87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 0.6% of Cigna Group shares are owned by insiders. Comparatively, 1.4% of Molina Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Cigna Group had 3 more articles in the media than Molina Healthcare. MarketBeat recorded 12 mentions for Cigna Group and 9 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.37 beat Cigna Group's score of 1.04 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cigna Group
8 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Molina Healthcare
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Cigna Group beats Molina Healthcare on 12 of the 17 factors compared between the two stocks.

How does Molina Healthcare compare to Centene?

Centene (NYSE:CNC) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

93.6% of Centene shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 0.4% of Centene shares are owned by company insiders. Comparatively, 1.4% of Molina Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Centene had 4 more articles in the media than Molina Healthcare. MarketBeat recorded 13 mentions for Centene and 9 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.37 beat Centene's score of 0.54 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
3 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Molina Healthcare
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Centene has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

Centene currently has a consensus target price of $63.22, suggesting a potential downside of 7.54%. Molina Healthcare has a consensus target price of $194.50, suggesting a potential downside of 20.07%. Given Centene's stronger consensus rating and higher possible upside, analysts clearly believe Centene is more favorable than Molina Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
11 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.25
Molina Healthcare
1 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.12

Molina Healthcare has a net margin of 0.42% compared to Centene's net margin of -3.25%. Molina Healthcare's return on equity of 8.76% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-3.25% 5.57% 1.54%
Molina Healthcare 0.42%8.76%2.32%

Molina Healthcare has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$198.10B0.17-$6.67B-$13.14N/A
Molina Healthcare$45.08B0.28$472M$3.3871.99

Summary

Molina Healthcare beats Centene on 10 of the 16 factors compared between the two stocks.

How does Molina Healthcare compare to Elevance Health?

Elevance Health (NYSE:ELV) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

Elevance Health has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

In the previous week, Elevance Health had 11 more articles in the media than Molina Healthcare. MarketBeat recorded 20 mentions for Elevance Health and 9 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.37 beat Elevance Health's score of 1.00 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
13 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Molina Healthcare
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health currently has a consensus price target of $430.76, indicating a potential upside of 1.26%. Molina Healthcare has a consensus price target of $194.50, indicating a potential downside of 20.07%. Given Elevance Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Elevance Health is more favorable than Molina Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
9 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.63
Molina Healthcare
1 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.12

Elevance Health has higher revenue and earnings than Molina Healthcare. Elevance Health is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$199.13B0.46$5.66B$23.5118.10
Molina Healthcare$45.08B0.28$472M$3.3871.99

Elevance Health has a net margin of 2.62% compared to Molina Healthcare's net margin of 0.42%. Elevance Health's return on equity of 15.58% beat Molina Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.62% 15.58% 5.57%
Molina Healthcare 0.42%8.76%2.32%

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 1.4% of Molina Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Elevance Health beats Molina Healthcare on 11 of the 16 factors compared between the two stocks.

How does Molina Healthcare compare to HCA Healthcare?

HCA Healthcare (NYSE:HCA) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership.

In the previous week, HCA Healthcare had 15 more articles in the media than Molina Healthcare. MarketBeat recorded 24 mentions for HCA Healthcare and 9 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.37 beat HCA Healthcare's score of 0.57 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HCA Healthcare
13 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Molina Healthcare
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

HCA Healthcare presently has a consensus price target of $496.77, indicating a potential upside of 27.11%. Molina Healthcare has a consensus price target of $194.50, indicating a potential downside of 20.07%. Given HCA Healthcare's stronger consensus rating and higher probable upside, research analysts plainly believe HCA Healthcare is more favorable than Molina Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HCA Healthcare
1 Sell rating(s)
9 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.54
Molina Healthcare
1 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.12

HCA Healthcare has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market.

62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by insiders. Comparatively, 1.4% of Molina Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

HCA Healthcare has a net margin of 8.89% compared to Molina Healthcare's net margin of 0.42%. Molina Healthcare's return on equity of 8.76% beat HCA Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
HCA Healthcare8.89% -295.93% 11.21%
Molina Healthcare 0.42%8.76%2.32%

HCA Healthcare has higher revenue and earnings than Molina Healthcare. HCA Healthcare is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HCA Healthcare$75.60B1.15$6.78B$29.0813.44
Molina Healthcare$45.08B0.28$472M$3.3871.99

Summary

HCA Healthcare beats Molina Healthcare on 12 of the 16 factors compared between the two stocks.

How does Molina Healthcare compare to Humana?

Molina Healthcare (NYSE:MOH) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

In the previous week, Humana had 3 more articles in the media than Molina Healthcare. MarketBeat recorded 12 mentions for Humana and 9 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.37 beat Humana's score of 1.05 indicating that Molina Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Molina Healthcare
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Humana
8 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

98.5% of Molina Healthcare shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 1.4% of Molina Healthcare shares are held by insiders. Comparatively, 0.2% of Humana shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Humana has higher revenue and earnings than Molina Healthcare. Humana is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Molina Healthcare$45.08B0.28$472M$3.3871.99
Humana$129.66B0.38$1.19B$9.3543.40

Molina Healthcare has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market. Comparatively, Humana has a beta of 0.71, indicating that its share price is 29% less volatile than the broader market.

Molina Healthcare currently has a consensus price target of $194.50, indicating a potential downside of 20.07%. Humana has a consensus price target of $315.70, indicating a potential downside of 22.21%. Given Molina Healthcare's higher probable upside, equities analysts plainly believe Molina Healthcare is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Molina Healthcare
1 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.12
Humana
2 Sell rating(s)
16 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.32

Humana has a net margin of 0.82% compared to Molina Healthcare's net margin of 0.42%. Humana's return on equity of 10.45% beat Molina Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Molina Healthcare0.42% 8.76% 2.32%
Humana 0.82%10.45%3.75%

Summary

Humana beats Molina Healthcare on 11 of the 17 factors compared between the two stocks.

Get Molina Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOH vs. The Competition

MetricMolina HealthcareMED IndustryMedical SectorNYSE Exchange
Market Cap$12.68B$56.78B$6.83B$23.40B
Dividend YieldN/A1.68%2.68%4.03%
P/E Ratio71.9927.0727.1531.08
Price / Sales0.280.68524.22154.92
Price / Cash16.2324.7929.2218.64
Price / Book3.242.9810.754.77
Net Income$472M$1.46B$3.58B$1.06B
7 Day Performance6.97%1.28%-2.10%-0.56%
1 Month Performance21.34%-3.39%3.32%-0.11%
1 Year Performance10.11%15.94%28.17%16.64%

Molina Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOH
Molina Healthcare
2.4052 of 5 stars
$243.34
+4.3%
$194.50
-20.1%
+5.0%$12.68B$45.08B71.9919,000
CI
Cigna Group
4.8519 of 5 stars
$281.97
-2.0%
$338.30
+20.0%
-3.1%$76.12B$274.90B11.9567,700
CNC
Centene
2.9461 of 5 stars
$66.02
-2.7%
$60.78
-7.9%
+114.3%$33.51B$194.78BN/A61,100
ELV
Elevance Health
4.5724 of 5 stars
$408.35
-2.3%
$419.16
+2.6%
+22.5%$90.75B$199.13B17.3797,100
HCA
HCA Healthcare
4.718 of 5 stars
$417.00
+1.6%
$503.00
+20.6%
+8.2%$91.07B$75.60B14.34320,000

Related Companies and Tools


This page (NYSE:MOH) was last updated on 7/13/2026 by MarketBeat.com Staff.
From Our Partners